// App-Quantinova.ai

TCT-428 : Bioresorbable Coronary Devices in Clinical Practice: 6-month Results of the Prospective REPARA Registry

Researchers

Presenter

  • Felipe Hernandez

Principal Investigators

  • Eduardo Pinar Bermudez

  • eduardo molina

  • Jose Diaz

  • Neus Salvatella

  • Juan Carlos Fernandez

  • Hipolito Gutierrez

  • Ramon Lopez Palop

  • Xavier Carrillo

  • Javier Zueco

Medical Centers

  • Hospital de la Princesa, Madrid, Spain

  • Hospital de Santa Maria, Lisbon, Portugal

  • Hospital Universitario Central de Asturias, Oviedo, Spain

  • Hospital Galdakao-Usansolo, Usansolo, Spain

  • Hospital Infanta Cristina, Badajoz, Spain

  • Hospital Universitario A Coruna, A Coruna, Spain

  • Hospital de Jaen, La GUardia de Jaen, Spain

  • Gastroenterology, Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal

  • Unknown, huelva, Spain

  • SERVICIO DE HEMODINAMICA, Murcia, Spain

  • Hospital Regional de Malage, Pozuelo de Alarcon, Spain

  • Unknown, Lisbon, Portugal

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Hospital Clinico Universitario, Santiago De Compostela, Spain

  • HU BELLVITGE, Barcelona, Spain

  • Hospital Clinico San Juan, Alicante, Spain

  • de Octubre, Madrid,Spain

  • Hospital Clinico Valencia, Valencia, Spain

  • Hospital Alvaro Cunqueiro, Vigo, Spain

  • Hospital Marques de Valdecilla, Santander, Spain

  • Hospital de Cabuenes, Gijon, Spain

Locations

  • Spain

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Angina

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved